C. Avendano and J.C. Menendez. Medicinal Chemistry of Anticancer Drugs. Elsevier, Amsterdam, 2nd edition, 2015.

B.A. Chabner and D.L. Longo (eds.). Cancer Chemotherapy and Biotherapy: Principles and Practice. Wolters Kluwer, Aalphen, 5th edition, 2010.

D.E.V. Wilman (ed). The chemistry of antitumour agents. Blackie, Glasgow and London, 1990.

G. Powis and R.A. Prough (eds.). Metabolism and Action of Anti-Cancer Drugs. Taylor and Francis, London, 1987.

T. Priestmann. Cancer Chemotherapy in Clinical Practice. Springer Verlag, London, 2008.

R.T. Skeel and S.N. Khleif (eds.). Handbook of Cancer Chemotherapy. Wolters Kluwer, Philadelphia, 8th edition, 2011.

B. Anderson and D. Murray (eds.).Clinically Relevant Resistance in Cancer Chemotherapy. Kluwer Academic Publishers, Doordrecht, 2002.

M.C. Perry, D.C. Doll and C.E. Freter (eds.). The Chemotherapy Source Book. Wolters Kluwer, Philadelphia, 5th edition, 2012.

Journal articles

B. Rosenberg, L. Vankamp and T. Krigas. Inhibition of cell division in E. coli by electrolysis products from a platinum electrode. Nature 205, 698-699 (1965).

H. Umezawa, K. Umezawa, T. Maeda and T. Takeuchi Okami. New antibiotics, bleomycin A and B. J. Antibiotics 19, 200-209 (1966).

L.G. Campana, B. Mali, G. Sersa, S. Valpione, C.A. Giorgi, P. Strojan, D. Miklavcic and C.R. Rossi. Electrochemotherapy in non-melanoma head and neck cancers: a retrospective analysis of the treated cases. British Journal of Oral and Maxillofacial Surgery 52, 937-964 (2014).

E.R. Jamieson and A.J. Lippard. Structure, recognition and processing of cisplatin-DNA adducts. Chemical Reviews 99, 2467-2498 (1999).

Z.H. Siddik. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22, 7265-7279 (2003).

I. Ott. On the medicinal chemistry of gold complexes as anticancer drugs. Coordination Chemistry Revews. 253, 1670-1681 (2009).

S. Dasari, P.B. Tchounwou and P. Bernard. Cisplatin in cancer therapy: Molecular mechanisms of action. European Journal  of Pharmacology 749, 364-378 (2014).

M. Rebucci and C. Michiels. Molecular aspects of cancer cell resistance to chemotherapy. Biochemical  Pharmacology  85, 1219-1226 (2013).

N. Normanno, A. de Luca, C. Bianco, L. Strizzi, M. Mancino, M.R. Maiello, A. Carotenuto, G. de Feo, F. Caponigro and D.S. Salomon. Epidermal growth factor receptor (EGFR) signalling in cancer. Gene 366, 2-16 (2006).

J. Fukai, K. Nishio, T. Hakura and F. Koizumi. Antitumor activity of cetuximab against malignant glioma cells overexpressing EGFR deletion mutant variant III. Cancer Science 99, 2062-2069 (2008).

J.E. Frampton. Cetuximab. A Review of its Use in Squamous Cell Carcinoma of the Head and Neck. Drugs 70, 1987-2010 (2010).

J. Capdevial, E. Elez, T. Macarulla, F.J. Ramos, M. Ruiz-Echarri and J. Tabernero. Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment. Cancer Treatment Reviews 35, 354-363 (2009).